All In MedTech

Device Trial Radar · NCT05627076

Analytical Validation of the abioSCOPE Device With the IVD CAPSULE PSP Test: Comparison of PSP Values Measured With Venous Whole Blood and Those Measured With Arterial Whole Blood.

Comparison of PSP Values Measured With Venous Whole Blood and Those Measured With Arterial Whole Blood.

Last checked: Nov 19, 2026Latest source record: Nov 25, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

46

Actual

Start

Aug 29, 2022

Primary completion

Oct 11, 2022

Study completion Oct 31, 2022

Sponsor

Lead sponsor
Abionic SANot on our public-company list
Sponsor type
Industry
First posted
Nov 25, 2022

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Abionic has developed a targeted, rapid test for pancreatic stone protein (PSP) in human K2-EDTA venous whole blood using the abioSCOPE instrument. Currently no PSP study comparaison has been done between venous and arterial whole blood. Abionic would like to confirm the equivalence of the PSP between venous whole blood and arterial whole blood.

Conditions

  • Sepsis
  • Sepsis Bacterial

Interventions

  • Blood SamplingDevice

    Blood samples will be collected for the PSP measurement using the abioSCOPE.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary assessmentTime frame: through study completion, an average of 1.5 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • CHU Limoges, Réanimation Polyvalente

    Limoges, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.